Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ono Pharmaceutical Co., Ltd.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female aged 18-85 (inclusive) with confirmed diagnosis of OHT or OAG
Confirmed diagnosis of bilateral OHT or mild to moderate chronic OAG
Able to undergo washout of all ocular drugs
An IOP ≥ 24 mmHg at 8:00 AM and ≥ 21 mmHg at 10:00 AM in at least 1 eye; but \< 36 mmHg in both eyes at both Day -5 and Day 1
Central corneal thickness 500-620 µm at screening and Day -5 in both eyes
Best corrected visual acuity (BCVA) of +0.7 Log Mar or better
You may not be if
Any history of severe ocular trauma in either eye at any time
History of angle closure or ocular laser surgery within the past 3 months or any refractive surgery procedure within the past 6 months of Screening Visit in the study eye(s)
Cataracts that prevent observation or photography of the fundus in either eye
